Clinical trial
S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C
NCT00475176 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00475176 |
|---|---|
| Title | S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C |
| Official title | Effects of S-Adenosyl Methionine (SAMe) on Viral and Cell Signaling Response to Combination Therapy for Chronic Hepatitis C |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Peginterferon alfa-2a, Ribavirin, S-adenosyl methionine for Chronic Liver Disease |
| Enrollment | 24 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | May 21, 2007 |
| Last update posted | Jul 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: